0001209191-21-034705.txt : 20210520
0001209191-21-034705.hdr.sgml : 20210520
20210520203614
ACCESSION NUMBER: 0001209191-21-034705
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210519
FILED AS OF DATE: 20210520
DATE AS OF CHANGE: 20210520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gruskin Daniel
CENTRAL INDEX KEY: 0001863053
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38707
FILM NUMBER: 21946308
MAIL ADDRESS:
STREET 1: 65 HAYDEN AVENUE
STREET 2: 2ND FLOOR
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001664106
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 471514975
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 65 HAYDEN AVE
STREET 2: 2ND FLOOR
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617-245-0399
MAIL ADDRESS:
STREET 1: 65 HAYDEN AVE
STREET 2: 2ND FLOOR
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-05-19
0
0001664106
LogicBio Therapeutics, Inc.
LOGC
0001863053
Gruskin Daniel
C/O LOGICBIO THERAPEUTICS, INC.
65 HAYDEN AVE, FLOOR 2
LEXINGTON
MA
02421
0
1
0
0
Chief Medical Officer
Employee Stock Option (Right to buy)
4.33
2021-05-19
4
A
0
60000
0.00
A
2031-05-19
Common Stock
60000
60000
D
The options were granted by the Issuer pursuant to its 2018 Equity Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal monthly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date.
/s/ Jonathan Quick, as Attorney-in-Fact
2021-05-20